Manuel E. Herrera Gutierrez
Research Subjects
Manuel E. Herrera Gutierrez has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Gemma Seller-Pérez
ICU, Carlos Haya Hospital, Carlos Haya Avenue s/n, 29010 Málaga, Spain
18 shared publications G. Seller-Pérez
Department of Intensive Care Medicine, Regional University Hospital of Malaga, Malaga, Spain
5 shared publicationsMiguel Lebrón-Gallardo
4 shared publications- Anibal Marinho
Department of Critical Care Medicine, Centro Hospitalario de Porto, Portugal
3 shared publications Esther Banderas-Bravo
3 shared publicationsG. Quesada-García
Intensive Care Medicine Unit, Regional University Hospital of Malaga, Spain
3 shared publications
Latest Publications
- Open Access
- 20 April 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-7
Evaluation of the registry DIALYREG for the assessment of continuous renal replacement techniques in the critically ill patient
Continuous renal replacement techniques (CRRT) can induce complications and monitoring is crucial to ensure patient safety. We designed a prospective multicenter observational and descriptive study using the DIALYREG registry, an online database located on a REDCap web-based platform that allows real-time data analysis. Our main objective was to identify CRRT-related complications in our intensive care units (ICUs) and implement security measures accordingly. From January 2019 to December 2020, we included 323 patients with admission diagnoses of medical illness (54%), sepsis (24%), postoperative care (20%), and trauma (2%). CRRT indications were homeostasis (42%), oliguria (26%), fluid overload (15%), and hemodynamic optimization (13%). The median initial therapy dose was 30 ml/kg/h (IQR 25–40), and dynamic adjustment was performed in 61% of the treatments. Sets were anticoagulated with heparin (40%), citrate (38%) or no anticoagulation (22%). Citrate anticoagulation had several advantages: more frequent dynamic CRRT dose adjustment (77% vs. 58% with heparin and 56% without anticoagulation, p < 0.05), longer duration of set (median of 55 h, IQR 24–72 vs. 23 h, IQR 12–48 with heparin and 12 h, IQR 12–31 without anticoagulation, p < 0.05), less clotting of the set (26% vs. 46.7% with heparin, p < 0.05), and lower incidence of hypophosphatemia (1% citrate vs. 6% with heparin and 5% without anticoagulation). It was also safe and effective in subgroup analysis of patients with liver disease or sepsis. The main global complications were hypothermia (16%), hypophosphatemia (13%) and metabolic acidosis (10%). Weaning of the therapy was achieved through early discontinuation (56%), nocturnal therapy transition (26%) and progressive SLED (18%). 52% of the patients were discharged from the hospital, while 43% died in the ICU and 5% died during hospitalization. We can conclude that the DIALYREG registry is a feasible tool for real-time control of CRRT in our ICU.
- 20 April 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-7
Open AccessEvaluation of the registry DIALYREG for the assessment of continuous renal replacement techniques in the critically ill patient
Continuous renal replacement techniques (CRRT) can induce complications and monitoring is crucial to ensure patient safety. We designed a prospective multicenter observational and descriptive study using the DIALYREG registry, an online database located on a REDCap web-based platform that allows real-time data analysis. Our main objective was to identify CRRT-related complications in our intensive care units (ICUs) and implement security measures accordingly. From January 2019 to December 2020, we included 323 patients with admission diagnoses of medical illness (54%), sepsis (24%), postoperative care (20%), and trauma (2%). CRRT indications were homeostasis (42%), oliguria (26%), fluid overload (15%), and hemodynamic optimization (13%). The median initial therapy dose was 30 ml/kg/h (IQR 25–40), and dynamic adjustment was performed in 61% of the treatments. Sets were anticoagulated with heparin (40%), citrate (38%) or no anticoagulation (22%). Citrate anticoagulation had several advantages: more frequent dynamic CRRT dose adjustment (77% vs. 58% with heparin and 56% without anticoagulation, p < 0.05), longer duration of set (median of 55 h, IQR 24–72 vs. 23 h, IQR 12–48 with heparin and 12 h, IQR 12–31 without anticoagulation, p < 0.05), less clotting of the set (26% vs. 46.7% with heparin, p < 0.05), and lower incidence of hypophosphatemia (1% citrate vs. 6% with heparin and 5% without anticoagulation). It was also safe and effective in subgroup analysis of patients with liver disease or sepsis. The main global complications were hypothermia (16%), hypophosphatemia (13%) and metabolic acidosis (10%). Weaning of the therapy was achieved through early discontinuation (56%), nocturnal therapy transition (26%) and progressive SLED (18%). 52% of the patients were discharged from the hospital, while 43% died in the ICU and 5% died during hospitalization. We can conclude that the DIALYREG registry is a feasible tool for real-time control of CRRT in our ICU.
- 1 June 2020
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 44 (5) , 275-282
C-reactive protein at ICU admission as a marker of early graft dysfunction after liver transplant. A prospective, single-center cohort study
- 1 June 2020
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 44 (5) , 275-282
C-reactive protein at ICU admission as a marker of early graft dysfunction after liver transplant. A prospective, single-center cohort study
- 1 April 2020
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 44 (3) , 150-159
Early graft dysfunction after liver transplant: Comparison of different diagnostic criteria in a single-center prospective cohort
- 1 April 2020
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 44 (3) , 150-159
Early graft dysfunction after liver transplant: Comparison of different diagnostic criteria in a single-center prospective cohort
- 1 June 2019
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 43 (5) , 302-316
Documento práctico del manejo de la hiponatremia en pacientes críticos
- 1 June 2019
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 43 (5) , 302-316
Documento práctico del manejo de la hiponatremia en pacientes críticos
- 1 May 2017
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 41 (4) , 262
Anomalous position of femoral dialysis catheters
- 1 May 2017
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 41 (4) , 262
Anomalous position of femoral dialysis catheters
- 1 August 2016
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 40 (6) , 374-382
Acute kidney injury: Renal disease in the ICU
- 1 August 2016
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 40 (6) , 374-382
Acute kidney injury: Renal disease in the ICU
- 31 October 2013
- Published by Elsevier in Journal of Critical Care
- Vol. 28 (5) , 687-694
Prevalence of acute kidney injury in intensive care units: The “COrte de prevalencia de disFunción RenAl y DEpuración en críticos” point-prevalence multicenter study
- 31 October 2013
- Published by Elsevier in Journal of Critical Care
- Vol. 28 (5) , 687-694
Prevalence of acute kidney injury in intensive care units: The “COrte de prevalencia de disFunción RenAl y DEpuración en críticos” point-prevalence multicenter study
- Open Access
- 23 June 2013
- Published by Wiley in Critical Care Research and Practice
- Vol. 2013, 1-2
Acute Kidney Injury in the Critically Ill Patient
- 23 June 2013
- Published by Wiley in Critical Care Research and Practice
- Vol. 2013, 1-2
Open AccessAcute Kidney Injury in the Critically Ill Patient
- Open Access
- 8 May 2013
- Published by Wiley in Critical Care Research and Practice
- Vol. 2013, 1-6
Estimating Kidney Function in the Critically Ill Patients
Glomerular filtration rate (GFR) is an accepted measure for assessment of kidney function. For the critically ill patient, creatinine clearance is the method of reference for the estimation of the GFR, although this is often not measured but estimated by equations (i.e., Cockroft-Gault or MDRD) not well suited for the critically ill patient. Functional evaluation of the kidney rests in serum creatinine (Crs) that is subjected to multiple external factors, especially relevant overhydration and loss of muscle mass. The laboratory method used introduces variations in Crs, an important fact considering that small increases in Crs have serious repercussion on the prognosis of patients. Efforts directed to stratify the risk of acute kidney injury (AKI) have crystallized in the RIFLE or AKIN systems, based in sequential changes in Crs or urine flow. These systems have provided a common definition of AKI and, due to their sensitivity, have meant a considerable advantage for the clinical practice but, on the other side, have introduced an uncertainty in clinical research because of potentially overestimating AKI incidence. Another significant drawback is the unavoidable period of time needed before a patient is classified, and this is perhaps the problem to be overcome in the near future.
- 8 May 2013
- Published by Wiley in Critical Care Research and Practice
- Vol. 2013, 1-6
Open AccessEstimating Kidney Function in the Critically Ill Patients
Glomerular filtration rate (GFR) is an accepted measure for assessment of kidney function. For the critically ill patient, creatinine clearance is the method of reference for the estimation of the GFR, although this is often not measured but estimated by equations (i.e., Cockroft-Gault or MDRD) not well suited for the critically ill patient. Functional evaluation of the kidney rests in serum creatinine (Crs) that is subjected to multiple external factors, especially relevant overhydration and loss of muscle mass. The laboratory method used introduces variations in Crs, an important fact considering that small increases in Crs have serious repercussion on the prognosis of patients. Efforts directed to stratify the risk of acute kidney injury (AKI) have crystallized in the RIFLE or AKIN systems, based in sequential changes in Crs or urine flow. These systems have provided a common definition of AKI and, due to their sensitivity, have meant a considerable advantage for the clinical practice but, on the other side, have introduced an uncertainty in clinical research because of potentially overestimating AKI incidence. Another significant drawback is the unavoidable period of time needed before a patient is classified, and this is perhaps the problem to be overcome in the near future.
- 1 October 2012
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 73 (4) , 855-860
A comparison of the effect of convection against diffusion in hemodynamics and cytokines clearance in an experimental model of septic shock
Replacement therapies based on the use of convection have value for the removal of inflammatory mediators. Such therapies have been proposed for the management of septic shock, but diffusion has not proved useful in this scenario, unless high-flow membranes are used. The exact role of diffusion in these cases remains to be clarified because continuous replacement therapies are usually delivered with low-flow membranes and mixed convection-diffusion modalities. However, studies specifically addressing this problem have not been performed. Our aim was to define the efficacy of hemofiltration (convection) and hemodialysis (diffusion) in cytokine clearance and hemodynamic improvement in an experimental model of septic shock. Shock was induced in 15 beagle dogs (weight 10-15 kg) by infusion of 1 mg/kg of ultrapure Escherichia coli lipopolysaccharide diluted in 20 mL saline for 10 minutes. Five animals were followed without interventions (controls), five animals were treated with convection (100 mL kg h) for 6 hours, and five animals were treated with diffusion (100 mL kg h) for 6 hours. All subjects in the control group died during the study, whereas all treated subjects survived. Mean arterial pressure, cardiac output, systolic variability volume, systemic vascular resistances, dPMax, and pulmonary compliance improved in treated subjects. However, the differences in mean arterial pressure and cardiac output were significant only in the convection group and not in the diffusion-treated group.Tumor necrosis factor α rose equally in all groups and decreased only in treated subjects. Interleukin 6 rose in the three groups but decreased only in the convection group and remained unchanged in the control and diffusion groups. Convection and diffusion improved survival and hemodynamic parameters in a septic shock model. Improvement was more pronounced with convection, a difference that may be explained by convective clearance of cytokines.
- 1 October 2012
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 73 (4) , 855-860
A comparison of the effect of convection against diffusion in hemodynamics and cytokines clearance in an experimental model of septic shock
Replacement therapies based on the use of convection have value for the removal of inflammatory mediators. Such therapies have been proposed for the management of septic shock, but diffusion has not proved useful in this scenario, unless high-flow membranes are used. The exact role of diffusion in these cases remains to be clarified because continuous replacement therapies are usually delivered with low-flow membranes and mixed convection-diffusion modalities. However, studies specifically addressing this problem have not been performed. Our aim was to define the efficacy of hemofiltration (convection) and hemodialysis (diffusion) in cytokine clearance and hemodynamic improvement in an experimental model of septic shock. Shock was induced in 15 beagle dogs (weight 10-15 kg) by infusion of 1 mg/kg of ultrapure Escherichia coli lipopolysaccharide diluted in 20 mL saline for 10 minutes. Five animals were followed without interventions (controls), five animals were treated with convection (100 mL kg h) for 6 hours, and five animals were treated with diffusion (100 mL kg h) for 6 hours. All subjects in the control group died during the study, whereas all treated subjects survived. Mean arterial pressure, cardiac output, systolic variability volume, systemic vascular resistances, dPMax, and pulmonary compliance improved in treated subjects. However, the differences in mean arterial pressure and cardiac output were significant only in the convection group and not in the diffusion-treated group.Tumor necrosis factor α rose equally in all groups and decreased only in treated subjects. Interleukin 6 rose in the three groups but decreased only in the convection group and remained unchanged in the control and diffusion groups. Convection and diffusion improved survival and hemodynamic parameters in a septic shock model. Improvement was more pronounced with convection, a difference that may be explained by convective clearance of cytokines.